A study labeled “National research priority” is coordinated by the hospital practitioner of vascular medicine at the Nancy CHRU and researcher, the Pr Stéphane Zuily, since April. Twenty-four centers are involved in twenty French hospitals. “Covi-Dose” aims to identify the best dose of anticoagulant in order to prevent the risk of thrombosis in patients hospitalized after infection with Covid-19. “We know that the virus kills and that it increases the risk of thrombosis,” says Stéphane Zuily. One in twenty people in conventional hospitalization and one in five patients in intensive care may be exposed to …
–
